These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3092099)

  • 1. Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage.
    Pfohl DN; Allen JI; Atkinson RL; Knopman DS; Malcolm RJ; Mitchell JE; Morley JE
    NIDA Res Monogr; 1986; 67():66-72. PubMed ID: 3092099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of opioid antagonists in the treatment of obesity. Results of a clinical trial with naltrexone].
    Novi RF; Lamberto M; Visconti P; Maurino M; Ardizzone A; Mantovan M; Meluzzi A; Francesetti G; Molinatti GM
    Minerva Endocrinol; 1990; 15(2):121-3. PubMed ID: 2098653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of naltrexone in obese humans.
    Malcolm R; O'Neil PM; Sexauer JD; Riddle FE; Currey HS; Counts C
    Int J Obes; 1985; 9(5):347-53. PubMed ID: 3908352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone (Trexan): a review of hepatotoxicity issues.
    Verebey KG; Mulé SJ
    NIDA Res Monogr; 1986; 67():73-81. PubMed ID: 3092100
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.
    Herman BH; Hammock MK; Arthur-Smith A; Kuehl K; Appelgate K
    Dev Pharmacol Ther; 1989; 12(3):118-27. PubMed ID: 2721334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of hepatotoxicity with naltrexone treatment.
    Sax DS; Kornetsky C; Kim A
    J Clin Pharmacol; 1994 Sep; 34(9):898-901. PubMed ID: 7983232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose naltrexone and liver function safety.
    Marrazzi MA; Wroblewski JM; Kinzie J; Luby ED
    Am J Addict; 1997; 6(1):21-9. PubMed ID: 9097868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced transaminase elevations: a prospective study.
    Guevara A; Labarca J; González-Martin G
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):137-41. PubMed ID: 8468111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of isocarboxazid.
    Zisook S
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
    Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
    Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of abnormal liver tests.
    Fregia A; Jensen DM
    Compr Ther; 1994; 20(1):50-4. PubMed ID: 8137620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum liver enzymes in obesity: a dilemma during clinical trials.
    Golik A; Rubio A; Weintraub M; Byrne L
    Int J Obes; 1991 Dec; 15(12):797-801. PubMed ID: 1794921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy.
    Levine RA; Ranek L
    Gastroenterology; 1970 Mar; 58(3):371-8. PubMed ID: 5437991
    [No Abstract]   [Full Text] [Related]  

  • 15. Mildly elevated liver transaminase levels in the asymptomatic patient.
    Giboney PT
    Am Fam Physician; 2005 Mar; 71(6):1105-10. PubMed ID: 15791889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method].
    Asada S; Ishimaru T; Kubo S; Kodama H; Masuda K
    Encephale; 1976; 2(1):73-83. PubMed ID: 770152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose naltrexone therapy and dietary counseling for obesity.
    Mitchell JE; Morley JE; Levine AS; Hatsukami D; Gannon M; Pfohl D
    Biol Psychiatry; 1987 Jan; 22(1):35-42. PubMed ID: 3790639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
    Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.